Biotech

All Articles

' Medical instinct' led FDA consultants to support Zevra's rare condition med

.Zevra Rehabs' unusual health condition medication appears to be on the path to permission this fall...

Pfizer takes $230M hit after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has actually blown...

AC Immune sees 'spots' possible in Alzheimer's medication records

.After more than twenty years of work with neurodegenerative diseases, Swiss biotech air conditionin...

GSK loses ph. 2 HPV injection over absence of best-in-class prospective

.GSK has broken up a period 2 human papillomavirus (HPV) vaccination from its own pipe after determi...

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.OS Therapies will certainly note on the NYSE American supply exchange this morning via a $6.4 thous...

ALX's fizzling CD47 reaction cost delivers sell spiraling down

.ALX Oncology's stage 2 stomach cancer action price has compromised. After viewing its CD47 blocker ...

Ionis centers eye ailment from intendeds of Roche-partnered possibility after data let down

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed requi...

Biogen's chief executive officer mentioned no unsafe handle 2023. He's ready to be bold

.While Biogen's pharma peers are hunting for late-stage possessions with little risk, CEO Chris Vieh...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Bio has actually been a biotech searching for a pipeline after it scrapped its own lead asse...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned rights to an early Alzheimer's illness program to Denali Therapeutics,...